Three new agents for immunotherapy trials: azimexon, bestatin, and tuftsin.
作者信息
Mathé G, Florentin I, Bruley-Rosset M, Goutner A, Serrou B
出版信息
Recent Results Cancer Res. 1982;80:331-3. doi: 10.1007/978-3-642-81685-7_53.
PMID:6977171
Abstract
摘要
Mathé G, Florentin I, Bruley-Rosset M, Goutner A, Serrou B
Recent Results Cancer Res. 1982;80:331-3. doi: 10.1007/978-3-642-81685-7_53.
Zotero 插件